GeoVax Labs (GOVX) vs Moolec Science SA (MLEC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Moolec Science SA is the larger company by market cap ($3.0 million vs $2.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GOVX | MLEC |
|---|---|---|
| Share price | $0.2866 | $4.19 |
| Market cap | $2.90M | $3.04M |
| 1-day change | -0.97% | -12.89% |
| EPS (TTM) | $-8.70 | $-199.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.75 | $23.22 |
| 52-week low | $0.277 | $3.08 |
| Distance from 52-week high | -98.18% | -81.96% |
| Analyst consensus | none | — |
| Avg. price target upside | +3389.18% | — |
| Average volume | 771.47K | 17.09K |
| Shares outstanding | 10.10M | 726.12K |
| Employees | 19 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About GeoVax Labs
GOVX stock →GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine.
Healthcare · Biotechnology · 19 employees
About Moolec Science SA
MLEC stock →Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.
Healthcare · Biotechnology
GOVX vs MLEC FAQ
Which is bigger, GeoVax Labs or Moolec Science SA?
Moolec Science SA (MLEC) is larger, with a market capitalization of $3.04M compared with $2.90M for GeoVax Labs (GOVX).
Are GeoVax Labs and Moolec Science SA in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.